CSF1R and neoplasm: A study revealed that CSF1R inhibitors facilitated macrophage repolarization by blocking cholesterol biosynthesis, which significantly increased the efficacy of PD-1 antibody treatment in colorectal cancer models.220 These findings underscore the potential of combining SASP-modulating therapies with ICIs to enhance anti-tumor immune responses.